Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: Systematic review and meta-analysis

BMJ

Volumn 337, Issue 7683, 2008, Pages 1388-1392

  Ford, Alexander C ^a   Talley, Nicholas J ^b   Spiegel, Brennan M R ^c   Foxx Orenstein, Amy E ^d   Schiller, Lawrence ^e   Quigley, Eamonn M M ^f   Moayyedi, Paul ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALVERINE; CIMETROPIUM; DICYCLOVERINE; ISPAGULA; MEBEVERINE; OTILONIUM BROMIDE; PARGEVERINE; PEPPERMINT OIL; PINAVERIUM; PIRENZEPINE; PRIFINIUM BROMIDE; ROCIVERINE; SCOPOLAMINE; SPASMOLYTIC AGENT; TRIMEBUTINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; CLINICAL TRIAL; DRUG EFFICACY; FIBER; HUMAN; IRRITABLE COLON; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WHEAT BRAN;

ADULT; DIETARY FIBER; HUMANS; IRRITABLE BOWEL SYNDROME; PARASYMPATHOLYTICS; PLANT OILS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 57749192461     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2313     Document Type: Review

References (19)

1. National Institute for Health and Clinical Excellence. Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. 2008. www.nice.org.uk/nicemedia/pdf/ IBSFullGuideline.pdf.
2. Spiller R, Aziz Q, Creed FEA, Houghton L, Hungin P, Jones R, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-98.
3. Harvey RF, Pomare EW, Heaton KW. Effects of increased dietary fibre on intestinal transit. Lancet 1973;301:1278-80.
4. Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. Gastroenterology 1991;101:55-65.
5. Jaliwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-47.
6. Brandt LJ, Bjorkman D, Fennerty MB, Locke III GR, Olden K, Peterson W, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97(suppl):S7-26.
7. Tack J, Fried M, Houghton LA, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Aliment Pharmacol Ther 2006;24:183-205.
8. Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:355-61.
9. Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum A. Meta-analysis: the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;20:1253-69.
10. Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005;Apr 18;(2):CD003460.
11. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and meta-analysis. Am J Gastroenterol 1998;93:1131-5.
12. Bijkerk CJ, Muris JWM, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-51.
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
15. Higgins JPT, Thompson SG, Deeks JJ, Attman OG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
16. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
17. Veldhuyzen Van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(suppl 2):1169-77.
18. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
19. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97(suppl 2):S2-5.